Submission for OMB Review; Generic for Administration for Children and Families (ACF) Program Monitoring Activities (New Collection), 55461-55462 [2020-19811]
Download as PDF
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
Comments due within 30 days of
publication. OMB is required to make a
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; Federal
Case Registry (FCR) (OMB #0970–
0421)
Office of Child Support
Enforcement, Administration for
Children and Families, Health and
Human Services (HHS).
ACTION: Request for public comment.
AGENCY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION:
Description: ACF implemented the
FCR within the Federal Parent Locator
ADDRESSES:
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the
Federal Case Registry (FCR). There are
no changes to the collection instruments
used for the FCR (current Office of
Management and Budget (OMB)
approval expires January 31, 2021).
SUMMARY:
55461
Service (FPLS) on October 1, 1998,
pursuant to federal law. The FCR is a
national database of information
pertaining to child support cases
processed by state child support
agencies, referred to as ‘‘IV–D’’ cases,
and non-IV–D support orders privately
established or modified by courts or
tribunals on or after October 1, 1998.
FCR information is submitted by each
State Case Registry (SCR), which is a
central registry of child support orders
and cases. The FCR automatically
compares new SCR submissions to
existing FCR information and notifies
state agencies if an IV–D case
participant in the state appears as a
participant in an IV–D or non-IV-case in
another state.
Respondents: State child support
enforcement agencies.
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of respondents
Total number
of responses
per
respondent
Average
burden hours
per response
Annual burden
hours
Appendix G: Input Record Layout ...................................................................
54
151
0.0333
272
Estimated Total Annual Burden
Hours: 272.
Authority: The information collection
activities pertaining to the FCR are
authorized by: 42 U.S.C. 653(h), which
requires the establishment of the FCR within
the FPLS; 42 U.S.C. 654a(e), which requires
state child support agencies to include a SCR
in the state’s automated system; and 42
U.S.C. 654a(f)(1), which requires states to
conduct information comparison activities
between the SCR and the FCR.
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–19840 Filed 9–4–20; 8:45 am]
BILLING CODE 4184–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
jbell on DSKJLSW7X2PROD with NOTICES
Submission for OMB Review; Generic
for Administration for Children and
Families (ACF) Program Monitoring
Activities (New Collection)
Office of Planning, Research,
and Evaluation, Administration for
Children and Families (ACF), Health
and Human Services (HHS).
ACTION: Request for public comment.
AGENCY:
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
The Administration for
Children and Families (ACF) intends to
request approval from the Office of
Management and Budget (OMB) for a
new generic clearance for information
collections related to ACF program
office monitoring activities. ACF
programs promote the economic and
social well-being of families, children,
individuals, and communities. The
proposed Generic for ACF Program
Monitoring Activities would allow ACF
program offices to collect standardized
information from recipients that receive
federal funds to ensure oversight,
evaluation, support purposes, and
stewardship of federal funds.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
ADDRESSES:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION:
Description: Program monitoring is a
post-award process through which ACF
assesses a recipient’s programmatic
performance and business management
performance. Monitoring activities are
necessary to ensure timely action by
ACF to support grantees and protect
federal interests.
Program offices would use
information collected under this generic
clearance to monitor funding recipient
activities and to provide support or take
appropriate action, as needed. The
information gathered will be used
primarily for internal purposes, but
aggregate data may be included in
public materials such as Reports to
Congress or program office documents.
Following standard OMB requirements,
ACF will submit a request for each
individual data collection activity under
this generic clearance. Each request will
include the individual form(s) or
instrument(s), a justification specific to
the individual information collection,
and any supplementary documents.
OMB is requested to review requests
within 10 days of submission.
Respondents: ACF funding recipients.
E:\FR\FM\08SEN1.SGM
08SEN1
55462
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
ANNUAL BURDEN ESTIMATES
Instrument
Total
number of
respondents
Total
number of
responses per
respondent
Average
burden hour
per response
Total burden
hours
Program Monitoring Forms ..............................................................................
1500
3
10
45,000
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–19811 Filed 9–4–20; 8:45 am]
BILLING CODE 4184–79–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–0907]
Medical Device User Fee Amendments
for Fiscal Years 2023 Through 2027;
Public Meeting; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration (FDA or the Agency) is
announcing a virtual public meeting to
discuss proposed recommendations for
the reauthorization of the Medical
Device User Fee Amendments (MDUFA)
for fiscal years (FYs) 2023 through 2027
(MDUFA V). MDUFA authorizes FDA to
collect user fees to support the process
for the review of medical device
applications. The current legislative
authority for MDUFA expires after
September 30, 2022, and new legislation
will be required for FDA to continue
collecting user fees for the medical
device program in future fiscal years.
The Federal Food, Drug, and Cosmetic
Act (FD&C Act) directs that FDA begin
MDUFA reauthorization by publishing a
notice in the Federal Register
requesting public input and holding a
public meeting where the public may
present its views on the reauthorization,
providing a period of 30 days after the
public meeting to obtain written
comments from the public suggesting
changes to MDUFA, and publishing the
comments on FDA’s website.
DATES: The public meeting will be held
on October 27, 2020, from 9 a.m. Eastern
Time to 2 p.m. Eastern Time. Submit
either electronic or written comments
on the medical device user fee program
and suggestions regarding the
commitments FDA should propose for
the next reauthorized program by
November 27, 2020. Registration to view
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
the meeting must be received by
October 23, 2020.
ADDRESSES: Registration to attend this
virtual public meeting and other
information can be found at https://
www.fda.gov/medical-devices/
workshops-conferences-medicaldevices/2020-medical-device-meetingsand-workshops. (Select this meeting
from the posted events list.) See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
Electronic comments must be submitted
on or before November 27, 2020. The
https://www.regulations.gov electronic
filing system will accept comments
until 11:59 p.m. Eastern Time on
November 27, 2020. Comments received
by mail/hand delivery/courier (for
written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–N–0907 for ‘‘Medical Device User
Fee Amendments for Fiscal Years 2023
Through 2027.’’ Received comments,
those filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
E:\FR\FM\08SEN1.SGM
08SEN1
Agencies
[Federal Register Volume 85, Number 174 (Tuesday, September 8, 2020)]
[Notices]
[Pages 55461-55462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19811]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Generic for Administration for
Children and Families (ACF) Program Monitoring Activities (New
Collection)
AGENCY: Office of Planning, Research, and Evaluation, Administration
for Children and Families (ACF), Health and Human Services (HHS).
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) intends to
request approval from the Office of Management and Budget (OMB) for a
new generic clearance for information collections related to ACF
program office monitoring activities. ACF programs promote the economic
and social well-being of families, children, individuals, and
communities. The proposed Generic for ACF Program Monitoring Activities
would allow ACF program offices to collect standardized information
from recipients that receive federal funds to ensure oversight,
evaluation, support purposes, and stewardship of federal funds.
DATES: Comments due within 30 days of publication. OMB must make a
decision about the collection of information between 30 and 60 days
after publication of this document in the Federal Register. Therefore,
a comment is best assured of having its full effect if OMB receives it
within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
SUPPLEMENTARY INFORMATION:
Description: Program monitoring is a post-award process through
which ACF assesses a recipient's programmatic performance and business
management performance. Monitoring activities are necessary to ensure
timely action by ACF to support grantees and protect federal interests.
Program offices would use information collected under this generic
clearance to monitor funding recipient activities and to provide
support or take appropriate action, as needed. The information gathered
will be used primarily for internal purposes, but aggregate data may be
included in public materials such as Reports to Congress or program
office documents. Following standard OMB requirements, ACF will submit
a request for each individual data collection activity under this
generic clearance. Each request will include the individual form(s) or
instrument(s), a justification specific to the individual information
collection, and any supplementary documents. OMB is requested to review
requests within 10 days of submission.
Respondents: ACF funding recipients.
[[Page 55462]]
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Total number of Average burden
Instrument Total number of responses per hour per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Program Monitoring Forms.................... 1500 3 10 45,000
----------------------------------------------------------------------------------------------------------------
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020-19811 Filed 9-4-20; 8:45 am]
BILLING CODE 4184-79-P